Commercial exploitation of transgenics

Area of Science:

• Biotechnology
• Molecular Biology
• Genetics

Background:

• Recombinant nucleic acid technology has revolutionized biological research and production.
• Traditional prokaryotic systems have limitations for certain biomolecule production.

Purpose of the Study:

• To review applications of recombinant nucleic acid technology in producing transgenic organisms.
• To compare eukaryotic and prokaryotic systems for recombinant biomolecule production.
• To discuss gene therapy and the creation of transgenic animals and plants.

Main Methods:

• Literature review of recombinant nucleic acid technology applications.
• Analysis of advantages of eukaryotic expression systems.
• Discussion of gene therapy, transgenic animal, and plant production.

Main Results:

• Eukaryotic systems offer distinct advantages for producing specific recombinant biomolecules.
• Successful examples of gene therapy, transgenic animals, and plants are presented.
• Potential risks, including new pathogen creation, are identified.

Conclusions:

• Recombinant nucleic acid technology provides powerful tools for creating transgenic organisms.
• Eukaryotic systems are often superior for complex biomolecule production.
• Ethical considerations and ecological impacts require careful evaluation.